Progyny, Inc. to Present at the BofA Securities SMID Cap 2H21 Ideas Conference

Progyny, a prominent fertility benefits management company, announces that CEO David Schlanger will participate in a fireside chat at the BofA Securities SMID Cap 2H21 Ideas Conference on August 10, 2021, at 1:00 PM ET.

Rhea-AI Summary

Progyny, a prominent fertility benefits management company, announces that CEO David Schlanger will participate in a fireside chat at the BofA Securities SMID Cap 2H21 Ideas Conference on August 10, 2021, at 1:00 PM ET. A live audiocast and replay will be accessible on Progyny's website. Progyny aims to enhance fertility solutions for employers and patients through dedicated support and a network of specialists. The company has received accolades for its growth and innovation in the healthcare sector.

Argus Session date unavailable

-12.83% session move Open Argus

Details

News Market Reaction – PGNY

The recorded move for PGNY in the trading session of this news was -12.83%.

Data tracked by StockTitan Argus. Session date unavailable.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

NEW YORK, Aug. 06, 2021 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a leading benefits management company specializing in fertility and family building benefits solutions in the United States, today announced that David Schlanger, Progyny’s Chief Executive Officer, will participate in a fireside chat at the BofA Securities SMID Cap 2H21 Ideas Conference on Tuesday, August 10, 2021 at 1:00 P.M. Eastern Time.

A live audiocast and replay will be available from the Events and Presentations section of Progyny’s website at http://investors.progyny.com. 

About Progyny

Progyny (Nasdaq: PGNY) is a leading fertility benefits management company in the US. We are redefining fertility and family building benefits, proving that a comprehensive and inclusive fertility solution can simultaneously benefit employers, patients, and physicians.  

Our benefits solution empowers patients with education and guidance from a dedicated Patient Care Advocate (PCA), provides access to a premier network of fertility specialists using the latest science and technologies, reduces healthcare costs for the nation’s leading employers, and drives optimal clinical outcomes. We envision a world where anyone who wants to have a child can do so. 

Headquartered in New York City, Progyny has been recognized for its leadership and growth by CNBC Disruptor 50, Modern Healthcare’s Best Places to Work in Healthcare, Financial Times, INC. 5000, and Crain’s Fast 50 for NYC. For more information, visit www.progyny.com.

For Further Information, Please Contact:
Investors:
James Hart
investors@progyny.com 

Media:
Selena Yang
media@progyny.com 

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What event will Progyny's CEO participate in on August 10, 2021?

Progyny's CEO, David Schlanger, will participate in a fireside chat at the BofA Securities SMID Cap 2H21 Ideas Conference.

What time is the fireside chat featuring Progyny's CEO?

The fireside chat is scheduled for 1:00 PM Eastern Time on August 10, 2021.

Where can I find the audiocast of the Progyny fireside chat?

The live audiocast and replay will be available on Progyny's website under the Events and Presentations section.

What is the main focus of Progyny's services?

Progyny specializes in fertility and family building benefits, aiming to provide comprehensive solutions for employers and patients.

What recognition has Progyny received for its impact in the healthcare field?

Progyny has been recognized by CNBC Disruptor 50, Modern Healthcare’s Best Places to Work in Healthcare, and Financial Times, among others.